TL;DR
Chris Johnson, ex-NFL star, disclosed his ALS diagnosis at age 39, describing a rapid disease progression. His story aims to raise awareness and advance research efforts.
Former NFL star and three-time Pro Bowl running back Chris Johnson revealed he has been diagnosed with ALS last year at age 39, during an interview on ‘Good Morning America’. Johnson described the diagnosis as a ‘shock’ and emphasized his commitment to fighting the disease, which has rapidly progressed since his symptoms first appeared.
In the interview, Johnson stated he noticed initial symptoms—weakness in his right hand—while in peak physical condition, contradicting common assumptions about ALS. His wife, Brittany Johnson, initially thought the weakness resulted from his football career, but further medical evaluation confirmed the diagnosis of sporadic ALS, which accounts for the majority of cases and has no known familial link, according to ABC News.
Johnson explained that his diagnosis came with bleak prognosis, with doctors suggesting only a few months to extend his life through medication. Despite this, he has engaged in experimental treatments, including participation in a clinical trial targeting inflammation, which his neurologist, Dr. Merit Cudkowicz, believes has contributed to his current condition.
His rapid disease progression has led him to use a speech-generating device, and he shared emotional reflections on how quickly ALS has affected his mobility—recalling moments like holding his daughter just over a year ago versus today. Johnson credits his family’s support as a vital source of strength amid his ongoing medical challenges.
Impact of Johnson’s Diagnosis on ALS Awareness and Research
Chris Johnson’s public disclosure of his ALS diagnosis brings increased visibility to a disease that affects thousands annually, often with rapid progression and limited treatment options. His story underscores the importance of ongoing research, clinical trials, and early diagnosis in managing ALS. It may inspire more support for research initiatives and encourage others to seek medical attention for early symptoms, potentially improving outcomes.
TalkingTiles AAC Device for Autism and Speech Therapy – Communication Tablet for Nonverbal, Speech Delay, and Non-Speaking Talker Tool – Alternative to PECS Cards and Speller Board
- Assistive Technology for Communication: Supports individuals with speech challenges
- Customizable with Images & Voice: Personalize communication pages easily
- Swipe Gestures for Motor Skills: Enhances fine motor development
As an affiliate, we earn on qualifying purchases.
As an affiliate, we earn on qualifying purchases.
ALS: Rapidly Progressive Disease with Limited Cure Options
ALS, or Lou Gehrig’s disease, is a neurodegenerative disorder leading to muscle weakness, paralysis, and respiratory failure. Most cases are sporadic, with no clear cause, though some research suggests links to injury or physical activity. The disease typically progresses swiftly, with most patients dying within three to five years of symptom onset. Treatments aim to slow progression but do not cure the disease, making early intervention and research critical. Johnson’s diagnosis highlights the unpredictable nature of ALS and the urgent need for effective therapies.
“At first, you’re in shock. Then you realize you have two choices. You can give up, or you can fight. I chose to fight.”
— Chris Johnson
Unclear Details About Johnson’s Long-Term Outlook
It remains uncertain how Johnson’s condition will evolve and whether ongoing experimental treatments will significantly extend his life or improve quality. The full impact of participation in clinical trials and the potential for future therapies are still under study, and medical prognosis for ALS varies widely among individuals.
Next Steps in Johnson’s Medical Journey and Advocacy
Johnson will continue receiving medical care, including participation in clinical trials, and may pursue additional experimental therapies. His public story aims to raise awareness and support for ALS research. The Johnson family plans to advocate for increased funding and early diagnosis initiatives, while medical teams monitor his condition for further progression.
Key Questions
What is ALS and how does it affect the body?
ALS is a neurodegenerative disease that damages nerve cells controlling muscle movement, leading to weakness, paralysis, and eventually affecting speech, swallowing, and breathing.
Can ALS be cured or slowed down?
Currently, there is no cure for ALS. Treatments can slow progression and improve quality of life, but the disease remains fatal in most cases within a few years of diagnosis.
How common is sporadic ALS compared to familial cases?
Most ALS cases, about 90%, are sporadic with no family history, and their causes are not well understood. The remaining cases are inherited, linked to genetic mutations.
What can be done to support ALS research?
Supporting funding for research, participating in clinical trials, and raising awareness are crucial steps to advancing understanding and developing effective treatments for ALS.
What are the signs of early ALS symptoms?
Early signs often include muscle weakness, twitching, cramping, or difficulty with fine motor tasks, such as gripping or buttoning. If symptoms appear, medical evaluation is advised.
Source: Google Trends
